{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:39:27Z","timestamp":1771328367331,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3501900"],"award-info":[{"award-number":["2022YFC3501900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital Institute of Pediatrics Clinical Training General Project","award":["LCYJ-2025-11"],"award-info":[{"award-number":["LCYJ-2025-11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06536-9","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T14:18:50Z","timestamp":1769177930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial use in pediatric hematopoietic stem cell transplantation in China: a retrospective multicenter cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ying","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"3","key":"6536_CR1","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","volume":"2","author":"A Gratwohl","year":"2015","unstructured":"Gratwohl A, Pasquini MC, Aljurf M, et al. One million Haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol. 2015;2(3):e91\u2013100. https:\/\/doi.org\/10.1016\/S2352-3026(15)00028-9.","journal-title":"Lancet Haematol"},{"key":"6536_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/PHMT.S366636","volume":"14","author":"AM Testi","year":"2023","unstructured":"Testi AM, Moleti ML, Angi A, Bianchi S, Barberi W, Capria S. Pediatric autologous hematopoietic stem cell transplantation: Safety, Efficacy, and patient Outcomes. Literature review. Pediatr Health Med Ther. 2023;14:197\u2013215. https:\/\/doi.org\/10.2147\/PHMT.S366636. Published 2023 May 31.","journal-title":"Pediatr Health Med Ther"},{"issue":"9","key":"6536_CR3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jtct.2024.06.021","volume":"30","author":"R Cusatis","year":"2024","unstructured":"Cusatis R, Litovich C, Feng Z, et al. Current trends and outcomes in cellular therapy activity in the united States, including prospective Patient-Reported outcomes data collection in the center for international blood and marrow transplant research registry. Transpl Cell Ther. 2024;30(9):917. https:\/\/doi.org\/10.1016\/j.jtct.2024.06.021.","journal-title":"Transpl Cell Ther"},{"key":"6536_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2147\/IDR.S451781","volume":"17","author":"R Zhang","year":"2024","unstructured":"Zhang R, Xiong Y, Zhang L, Liu L, Epidemiology. Microbiology, and risk factors of bacterial bloodstream infections in patients after allogeneic hematopoietic stem cell transplantation. Infect Drug Resist. 2024;17:1561\u20139. https:\/\/doi.org\/10.2147\/IDR.S451781.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"6536_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/cid\/ciae612","volume":"80","author":"C Li","year":"2025","unstructured":"Li C, Zhu DP, Chen J, et al. Invasive fungal disease in patients undergoing allogeneic hematopoietic stem cell transplantation in china: A multicenter epidemiological study (CAESAR 2.0). Clin Infect Dis. 2025;80(4):807\u201316. https:\/\/doi.org\/10.1093\/cid\/ciae612.","journal-title":"Clin Infect Dis"},{"issue":"45","key":"6536_CR6","doi-asserted-by":"publisher","first-page":"e1931","DOI":"10.1097\/MD.0000000000001931","volume":"94","author":"L Wang","year":"2015","unstructured":"Wang L, Wang Y, Fan X, Tang W, Hu J. Prevalence of resistant Gram-Negative bacilli in bloodstream infection in febrile neutropenia patients undergoing hematopoietic stem cell transplantation: A single center retrospective cohort study. Med (Baltim). 2015;94(45):e1931. https:\/\/doi.org\/10.1097\/MD.0000000000001931.","journal-title":"Med (Baltim)"},{"issue":"4","key":"6536_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jmii.2023.01.017","volume":"56","author":"M Zeng","year":"2023","unstructured":"Zeng M, Xia J, Zong Z, et al. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect. 2023;56(4):653\u201371. https:\/\/doi.org\/10.1016\/j.jmii.2023.01.017.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"6536_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","volume":"55","author":"J Styczy\u0144ski","year":"2020","unstructured":"Styczy\u0144ski J, Tridello G, Koster L, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transpl. 2020;55(1):126\u201336. https:\/\/doi.org\/10.1038\/s41409-019-0624-z.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"6536_CR9","doi-asserted-by":"publisher","first-page":"2178805","DOI":"10.1080\/19490976.2023.2178805","volume":"15","author":"YF van Lier","year":"2023","unstructured":"van Lier YF, Vos J, Blom B, Hazenberg MD. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease. Gut Microbes. 2023;15(1):2178805. https:\/\/doi.org\/10.1080\/19490976.2023.2178805.","journal-title":"Gut Microbes"},{"issue":"5","key":"6536_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cmi.2024.01.005","volume":"30","author":"L Biyun","year":"2024","unstructured":"Biyun L, Yahui H, Yuanfang L, Xifeng G, Dao W. Risk factors for invasive fungal infections after Haematopoietic stem cell transplantation: a systematic review and meta-analysis. Clin Microbiol Infect. 2024;30(5):601\u201310. https:\/\/doi.org\/10.1016\/j.cmi.2024.01.005.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"6536_CR11","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cmi.2023.04.021","volume":"29","author":"K Manothummetha","year":"2023","unstructured":"Manothummetha K, Mongkolkaew T, Tovichayathamrong P, et al. Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and Haematopoietic stem cell transplant recipients: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(10):1272\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2023.04.021.","journal-title":"Clin Microbiol Infect"},{"key":"6536_CR12","doi-asserted-by":"publisher","unstructured":"Paw Cho Sing E, Tomlinson GA, Schechter T et al. Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score-weighted, retrospective assessment. Support Care Cancer. 2024;32(8):552. Published 2024 Jul 25. https:\/\/doi.org\/10.1007\/s00520-024-08732-8","DOI":"10.1007\/s00520-024-08732-8"},{"issue":"Suppl 1","key":"6536_CR13","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.cmi.2023.09.001","volume":"30","author":"N Hassoun-Kheir","year":"2024","unstructured":"Hassoun-Kheir N, Guedes M, Ngo Nsoga MT, et al. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe. Clin Microbiol Infect. 2024;30(Suppl 1):S14\u201325. https:\/\/doi.org\/10.1016\/j.cmi.2023.09.001.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"6536_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/jama.2018.1251","volume":"320","author":"S Alexander","year":"2018","unstructured":"Alexander S, Fisher BT, Gaur AH, et al. Effect of Levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: A randomized clinical trial. JAMA. 2018;320(10):995\u20131004. https:\/\/doi.org\/10.1001\/jama.2018.1251.","journal-title":"JAMA"},{"issue":"1","key":"6536_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cid\/ciz1082","volume":"71","author":"T Lehrnbecher","year":"2020","unstructured":"Lehrnbecher T, Fisher BT, Phillips B, et al. Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation. Clin Infect Dis. 2020;71(1):226\u201336. https:\/\/doi.org\/10.1093\/cid\/ciz1082.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"6536_CR16","doi-asserted-by":"publisher","first-page":"106571","DOI":"10.1016\/j.jinf.2025.106571","volume":"91","author":"F Baccelli","year":"2025","unstructured":"Baccelli F, Aguilar-Guisado, CG Vidal M, et al. Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in europe: A systematic review by the European conference on infections in leukemia (ECIL). J Infect. 2025;91(3):106571. https:\/\/doi.org\/10.1016\/j.jinf.2025.106571.","journal-title":"J Infect"},{"issue":"7","key":"6536_CR17","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00277-021-04521-z","volume":"100","author":"S Butera","year":"2021","unstructured":"Butera S, Cerrano M, Brunello L, et al. Impact of anti-thymocyte Globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience. Ann Hematol. 2021;100(7):1837\u201347. https:\/\/doi.org\/10.1007\/s00277-021-04521-z.","journal-title":"Ann Hematol"},{"issue":"12","key":"6536_CR18","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41409-022-01793-5","volume":"57","author":"D Zama","year":"2022","unstructured":"Zama D, Masetti R, Baccelli F, et al. Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the stem cell transplant and the infectious disease working groups of the AIEOP network. Bone Marrow Transpl. 2022;57(12):1851\u20133. https:\/\/doi.org\/10.1038\/s41409-022-01793-5.","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"6536_CR19","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41409-020-0811-y","volume":"55","author":"A Verlinden","year":"2020","unstructured":"Verlinden A, Mikulska M, Knelange NS, Averbuch D, Styczynski J, Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT). Current antimicrobial practice in febrile neutropenia across Europe and asia: the EBMT infectious disease working party survey. Bone Marrow Transpl. 2020;55(8):1588\u201394. https:\/\/doi.org\/10.1038\/s41409-020-0811-y.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"6536_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-016-0305-y","volume":"9","author":"L Gao","year":"2016","unstructured":"Gao L, Sun Y, Meng F, et al. Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in china: a multicenter prospective observational study. J Hematol Oncol. 2016;9(1):97. https:\/\/doi.org\/10.1186\/s13045-016-0305-y. Published 2016 Sep 23.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"6536_CR21","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/antibiotics11101316","volume":"11","author":"G Boss\u00f9","year":"2022","unstructured":"Boss\u00f9 G, Di Sario R, Muratore E, et al. Novel insights into fungal infections prophylaxis and treatment in pediatric patients with cancer. Antibiot (Basel). 2022;11(10):1316. https:\/\/doi.org\/10.3390\/antibiotics11101316.","journal-title":"Antibiot (Basel)"},{"issue":"4","key":"6536_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00520-025-09337-5","volume":"33","author":"L Martin","year":"2025","unstructured":"Martin L, Carlesse F, Elgarten CW, et al. Addressing infectious challenges in pediatric cancer and hematopoietic cell transplantation: insights from the umbrella working group. Support Care Cancer. 2025;33(4):264. https:\/\/doi.org\/10.1007\/s00520-025-09337-5. Published 2025 Mar 11.","journal-title":"Support Care Cancer"},{"key":"6536_CR23","doi-asserted-by":"publisher","unstructured":"Pagano L, Maschmeyer G, Lamoth F et al. Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). Leukemia. 2025;39(7):1547\u20131557. https:\/\/doi.org\/10.1038\/s41375-025-02586-7","DOI":"10.1038\/s41375-025-02586-7"},{"issue":"12","key":"6536_CR24","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1016\/S2352-3026(22)00293-9","volume":"9","author":"YJ Chang","year":"2022","unstructured":"Chang YJ, Pei XY, Huang XJ. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions. Lancet Haematol. 2022;9(12):e919\u201329. https:\/\/doi.org\/10.1016\/S2352-3026(22)00293-9.","journal-title":"Lancet Haematol"},{"key":"6536_CR25","unstructured":"Xiao Yonghong. Clinical application management measures for antimicrobial drugs \u2014 A guide to antimicrobial drug management in medical institutions. Chin Pharmacist 2012, 9(06): 8\u201313. DOI: CNKI:SUN:ZYYS.0.2012-06-005."},{"issue":"4","key":"6536_CR26","doi-asserted-by":"publisher","first-page":"e0159724","DOI":"10.1128\/aac.01597-24","volume":"69","author":"Y-H Chen","year":"2025","unstructured":"Chen Y-H, Sun AY-E, Narain K, et al. Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis. Antimicrob Agents Chemother. 2025;69(4):e0159724. https:\/\/doi.org\/10.1128\/aac.01597-24.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"6536_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cmi.2024.09.015","volume":"31","author":"AG Er","year":"2025","unstructured":"Er AG, Aslan AT, Mikulska M, Akova M. Prevention and treatment of bacterial infections in patients with haematological cancers and Haematopoietic stem cell transplantation: headways and shortcomings. Clin Microbiol Infect. 2025;31(1):24\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2024.09.015.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"6536_CR28","first-page":"170","volume":"28","author":"R Dhanya","year":"2022","unstructured":"Dhanya R, Agarwal RK, Ramprakash S, et al. Do weekly surveillance cultures contribute to antibiotic stewardship and correlate with outcome of HSCT in children? A multicenter Real-World experience of 5 years from the Indian Subcontinent. Transpl Cell Ther. 2022;28(3):170. .e1-170.e7.","journal-title":"Transpl Cell Ther"},{"issue":"1","key":"6536_CR29","doi-asserted-by":"publisher","first-page":"31322","DOI":"10.1038\/s41598-024-82795-9","volume":"14","author":"J Abi Frem","year":"2024","unstructured":"Abi Frem J, Khazzeka A, Allaw F, et al. Ceftazidime-avibactam for the treatment of febrile neutropenia in HSCT recipients and acute leukemia patients post induction chemotherapy. Sci Rep. 2024;14(1):31322. https:\/\/doi.org\/10.1038\/s41598-024-82795-9. Published 2024 Dec 28.","journal-title":"Sci Rep"},{"issue":"Suppl 7","key":"6536_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/imj.15588","volume":"51","author":"BW Teh","year":"2021","unstructured":"Teh BW, Yeoh DK, Haeusler GM, et al. Consensus guidelines for antifungal prophylaxis in haematological malignancy and Haemopoietic stem cell transplantation, 2021. Intern Med J. 2021;51(Suppl 7):67\u201388. https:\/\/doi.org\/10.1111\/imj.15588.","journal-title":"Intern Med J"},{"issue":"12","key":"6536_CR31","first-page":"1195","volume":"30","author":"CKF Neuerburg","year":"2024","unstructured":"Neuerburg CKF, Schmitz F, Schmitz MT, et al. Antibiotic prophylaxis during allogeneic stem cell transplantation-A comprehensive single center retrospective analysis. Transpl Cell Ther. 2024;30(12):1195. .e1-1195.e13.","journal-title":"Transpl Cell Ther"},{"issue":"8","key":"6536_CR32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jtct.2025.05.007","volume":"31","author":"P Palla","year":"2025","unstructured":"Palla P, Konstantinidis I, Boussiou Z, et al. Bloodstream infections due to Multidrug-Resistant Gram-Negative organisms in hematopoietic stem cell transplant recipients: A multicenter Case-Control study in a High-Prevalence area. Transpl Cell Ther. 2025;31(8):596. https:\/\/doi.org\/10.1016\/j.jtct.2025.05.007.","journal-title":"Transpl Cell Ther"},{"key":"6536_CR33","doi-asserted-by":"publisher","first-page":"101955","DOI":"10.1016\/j.bpg.2024.101955","volume":"72","author":"P J\u00f3zefczuk","year":"2024","unstructured":"J\u00f3zefczuk P, Bili\u0144ski J, Minkowska A, \u0141aguna P. Gut Microbiome in children undergoing hematopoietic stem cell transplantation. Best Pract Res Clin Gastroenterol. 2024;72:101955. https:\/\/doi.org\/10.1016\/j.bpg.2024.101955.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"6536_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/antibiotics10030266","volume":"10","author":"E Castagnola","year":"2021","unstructured":"Castagnola E, Bagnasco F, Mesini A, et al. Antibiotic resistant bloodstream infections in pediatric patients receiving chemotherapy or hematopoietic stem cell transplant: factors associated with development of Resistance, intensive care admission and mortality. Antibiot (Basel). 2021;10(3):266. https:\/\/doi.org\/10.3390\/antibiotics10030266. Published 2021 Mar 5.","journal-title":"Antibiot (Basel)"},{"key":"6536_CR35","doi-asserted-by":"publisher","unstructured":"Muratore E, Baccelli F, Leardini D et al. Antimicrobial Stewardship Interventions in Pediatric Oncology: A Systematic Review. J Clin Med. 2022;11(15):4545. Published 2022 Aug 4. https:\/\/doi.org\/10.3390\/jcm11154545.","DOI":"10.3390\/jcm11154545"},{"issue":"1","key":"6536_CR36","doi-asserted-by":"publisher","first-page":"29296","DOI":"10.1038\/s41598-024-80163-1","volume":"14","author":"C Liberati","year":"2024","unstructured":"Liberati C, Barbieri E, Cavagnero F, et al. Impact of a two step antimicrobial stewardship program in a paediatric haematology and oncology unit. Sci Rep. 2024;14(1):29296. https:\/\/doi.org\/10.1038\/s41598-024-80163-1. Published 2024 Nov 26.","journal-title":"Sci Rep"},{"key":"6536_CR37","doi-asserted-by":"publisher","first-page":"782530","DOI":"10.3389\/fped.2021.782530","volume":"9","author":"O Zajac-Spychala","year":"2022","unstructured":"Zajac-Spychala O, Kampmeier S, Lehrnbecher T, Groll AH. Infectious complications in paediatric haematopoetic cell transplantation for acute lymphoblastic leukemia: current status. Front Pediatr. 2022;9:782530. https:\/\/doi.org\/10.3389\/fped.2021.782530. Published 2022 Feb 10.","journal-title":"Front Pediatr"},{"issue":"4","key":"6536_CR38","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1002\/pdi3.101","volume":"2","author":"TW Yeung","year":"2024","unstructured":"Yeung TW, Chan WYK, Wong SCY, Lee PPW, Cheuk DKL, Leung W. High infection rates and risk-adapted prevention strategies in contemporary pediatric allogeneic hematopoietic stem cell transplantation. Pediatr Discov. 2024;2(4):e101. https:\/\/doi.org\/10.1002\/pdi3.101. Published 2024 Jul 14.","journal-title":"Pediatr Discov"},{"issue":"9","key":"6536_CR39","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/medicina60091395","volume":"60","author":"S \u0160egulja","year":"2024","unstructured":"\u0160egulja S, Vrane\u0161evi\u0107 K, \u0110or\u0111evi\u0107 A, Roganovi\u0107 J. Infections in children with acute lymphoblastic leukemia. Med (Kaunas). 2024;60(9):1395. https:\/\/doi.org\/10.3390\/medicina60091395. Published 2024 Aug 26.","journal-title":"Med (Kaunas)"},{"issue":"6","key":"6536_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11912-022-01192-5","volume":"24","author":"S Villeneuve","year":"2022","unstructured":"Villeneuve S, Aftandilian C. Neutropenia and infection prophylaxis in childhood cancer. Curr Oncol Rep. 2022;24(6):671\u201386. https:\/\/doi.org\/10.1007\/s11912-022-01192-5.","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"6536_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","volume":"45","author":"R Bellmann","year":"2017","unstructured":"Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45(6):737\u201379. https:\/\/doi.org\/10.1007\/s15010-017-1042-z.","journal-title":"Infection"},{"issue":"7","key":"6536_CR42","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1080\/10428194.2023.2203289","volume":"64","author":"CC Hu","year":"2023","unstructured":"Hu CC, Subramanian R, Grigg A. Evaluation of a safe neutrophil count for cessation of intravenous antibiotics and early hospital discharge in stable, afebrile patients recovering after acute myeloid leukemia therapy or an autograft. Leuk Lymphoma. 2023;64(7):1322\u20139. https:\/\/doi.org\/10.1080\/10428194.2023.2203289.","journal-title":"Leuk Lymphoma"},{"key":"6536_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/164_2021_544","volume":"272","author":"TF Michniacki","year":"2022","unstructured":"Michniacki TF, Choi SW, Peltier DC. Immune suppression in allogeneic hematopoietic stem cell transplantation. Handb Exp Pharmacol. 2022;272:209\u201343. https:\/\/doi.org\/10.1007\/164_2021_544.","journal-title":"Handb Exp Pharmacol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06536-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06536-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06536-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:46:05Z","timestamp":1771325165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06536-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6536"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06536-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Capital Center for Children\u2019s Health, Capital Medical University. Since the data were collected retrospectively and anonymized, the ethics committee waived the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}